Cleared Traditional

AxCess® Expandable Interbody System (K243739) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K243739 · Elliquence, LLC · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2025
Decision
51d
Days
Class 2
Risk

K243739 is an FDA 510(k) clearance for the AxCess® Expandable Interbody System. Classified as Intervertebral Fusion Device With Bone Graft, Lumbar within the MAX classification (a category for intervertebral fusion devices and spinal implants), Class II - Special Controls.

Submitted by Elliquence, LLC (Baldwin, US). The FDA issued a Cleared decision on January 24, 2025 after a review of 51 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Elliquence, LLC devices

Submission Details

510(k) Number K243739 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 04, 2024
Decision Date January 24, 2025
Days to Decision 51 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
71d faster than avg
Panel avg: 122d · This submission: 51d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MAX Intervertebral Fusion Device With Bone Graft, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Empirical Technologies
Nathan Wright

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MAX Intervertebral Fusion Device With Bone Graft, Lumbar

All 471
Devices cleared under the same product code (MAX) and FDA review panel - the closest regulatory comparables to K243739.
Tesera-k PL System and Tesera-k XL System
K242771 · Kyocera Medical Technologies, Inc. · Mar 2025
FortiVy™ OsteoVy™ Lumbar IBF
K241783 · Vy Spine, LLC · Mar 2025
IdentiTi Porous Ti Interbody System
K241375 · Alphatec Spine · Feb 2025
ProLift Pivot Expandable Spacer System
K243668 · Life Spine, Inc. · Jan 2025
Idys® LIF
K243670 · Clariance · Dec 2024
DZ-Tabone Intervertebral Body Fusion Device
K241073 · Shenzhen Dazhou Medical Technology Co., Ltd. · Dec 2024